This project will use Magnetic Resonance Spectroscopy lmaging (MRSI) technology to measure concentrations of neurotransmitters - chemicals crucial for communication in the brain and evaluate the relationship between brain function and brain structure normal and stroke patients to improve the early detection of the disease. This project has implications for translation to clinical samples such as stroke, Alzheimer's disease, schizophrenia, multiple sclerosis, dyslexia, as well as cognitive remediation and brain-stimulation approaches to functional recovery.
Researchers
Dr Renate Thienel, Frini Karayanidis, Juanita Todd, Peter Stanwell, Mark Parsons, Chris Levi
Research Area
Project type
Project Grant
Year of funding
2013